News - Respiratory and Pulmonary, Healthcare

Filter

Popular Filters

New agreement with GSK provides new medicines, saves millions for New Zealand

New agreement with GSK provides new medicines, saves millions for New Zealand

11-12-2013

A new agreement with the local subsidiary of UK pharma giant GlaxoSmithKline by New Zealand’s Pharmaceutical…

Anti-viralsAsia-PacificGlaxoSmithKlineHealthcareHematologyNew ZealandPharmaceuticalPricingRespiratory and PulmonarySeretideSerevent Diskus

GA and PhRMA partner on pilot scheme to enhance patient engagement in three therapy areas

05-11-2013

The USA’s Genetic Alliance and the Pharmaceutical Research and Manufacturers of America have announced…

Gastro-intestinalsHealthcareHematologyNorth AmericaPharmaceuticalRespiratory and Pulmonary

UK's NICE approves NHS funding for Novartis' Xolair for all eligible patients

24-07-2013

The UK's drugs watch dog the National Institute for Health and Care Excellence (NICE) has stipulated…

EuropeHealthcareNovartisPharmaceuticalRespiratory and PulmonaryXolair

New Zealand's PHARMAC to fund alternative treatments for asthma, scabies from Merck

31-07-2012

New Zealand's Pharmaceutical Management Agency PHARMAC is to fund a treatment for pre-schoolers with…

Asia-PacificDermatologicalsHealthcareMerck & CoPharmaceuticalPricingRespiratory and PulmonarySingulairStromectil

South Africa debuts new five-year HIV and tuberculosis plan

05-12-2011

Coinciding with Worlds AIDS day last week, the South African government launched its new national strategic…

Anti-viralsHealthcarePharmaceuticalRespiratory and PulmonaryRest of the World

New global data on influenza vaccine provision and level of support for immunization policies

28-11-2011

The findings of two studies being published this week in peer-reviewed journals look at global vaccination…

GlobalHealthcarePharmaceuticalRespiratory and PulmonaryVaccines

Longer-term safety profile of InterMune’s Esbriet in IPF demonstrated; Call for greater awareness of PF

26-09-2011

US biotech firm InterMune (Nasdaq: ITMN) has reported that new data at the European Respiratory Society…

BiotechnologyCardio-vascularEsbrietHealthcareInterMunePharmaceuticalResearchRespiratory and Pulmonary

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top